Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection

Virology

Volumn 485, Issue , 2015, Pages 36-46

  Lee, Young Tae ^a   Kim, Ki Hye ^a   Hwang, Hye Suk ^a   Lee, Youri ^a   Kwon, Young Man ^a   Ko, Eun Ju ^a   Jung, Yu Jin ^a   Lee, Yu Na ^a   Kim, Min Chul ^a,b   Kang, Sang Moo ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

Alveolar macrophages; Clodronate liposome; Formalin inactivated RSV; Respiratory syncytial virus (RSV); Vaccine

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 4; RESPIRATORY SYNCYTIAL VIRUS VACCINE; CLODRONIC ACID; FORMALDEHYDE; INACTIVATED VACCINE; LIPOSOME;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MEDIASTINUM LYMPH NODE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PNEUMONIA; PRIORITY JOURNAL; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRAL CLEARANCE; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DENDRITIC CELL; DRUG EFFECTS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNIZATION; IMMUNOLOGY; LUNG; PATHOLOGY; PHENOTYPE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CLODRONIC ACID; DENDRITIC CELLS; EOSINOPHILS; FEMALE; FORMALDEHYDE; IMMUNITY, INNATE; IMMUNIZATION; INTERLEUKIN-4; LIPOSOMES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; NEUTROPHILS; PHENOTYPE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINES, INACTIVATED;

EID: 84937550128     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.07.001     Document Type: Article

References (45)

1. Beaty S.R., Rose C.E., Sung S.S. Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation. J. Immunol. 2007, 178:1882-1895.
2. Becker S., Quay J., Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 1991, 147:4307-4312.
3. Broug-Holub E., Toews G.B., van Iwaarden J.F., Strieter R.M., Kunkel S.L., Paine R., Standiford T.J. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 1997, 65:1139-1146.
4. Bukreyev A., Belyakov I.M., Prince G.A., Yim K.C., Harris K.K., Berzofsky J.A., Collins P.L. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J. Virol. 2005, 79:9515-9526.
5. Castilow E.M., Legge K.L., Varga S.M. Cutting edge: eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease. J. Immunol. 2008, 181:6692-6696.
6. Chang J., Srikiatkhachorn A., Braciale T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J. Immunol. 2001, 167:4254-4260.
7. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5:1219-1226.
8. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 2008, 83:64-70.
9. Fitzgerald-Bocarsly P., Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie 2007, 89:843-855.
10. Goritzka M., Makris S., Kausar F., Durant L.R., Pereira C., Kumagai Y., Culley F.J., Mack M., Akira S., Johansson C. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J. Exp. Med. 2015, 212:699-714.
11. Hall J.D., Woolard M.D., Gunn B.M., Craven R.R., Taft-Benz S., Frelinger J.A., Kawula T.H. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 2008, 76:5843-5852.
12. Holt P.G. Antigen presentation in the lung. Am. J. Respir. Crit. Care Medicine 2000, 162:S151-156.
13. Jakubzick C., Tacke F., Llodra J., van Rooijen N., Randolph G.J. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 2006, 176:3578-3584.
14. Johnson T.R., Graham B.S. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J.Virol. 1999, 73:8485-8495.
15. Johnson T.R., Parker R.A., Johnson J.E., Graham B.S. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J. Immunol. 2003, 170:2037-2045.
16. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89:405-421.
17. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrott R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89:422-434.
18. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrott R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89:422-434.
19. Ko E.J., Kwon Y.M., Lee J.S., Hwang H.S., Yoo S.E., Lee Y.N., Lee Y.T., Kim M.C., Cho M.K., Lee Y.R., Quan F.S., Song J.M., Lee S., Moore M.L., Kang S.M. Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells. Nanomed.: Nanotechnol. Biol. Med. 2015, 11:99-108.
20. Lambrecht B.N., Hammad H. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 2012, 30:243-270.
21. Lee J.S., Kwon Y.M., Hwang H.S., Lee Y.N., Ko E.J., Yoo S.E., Kim M.C., Kim K.H., Cho M.K., Lee Y.T., Lee Y.R., Quan F.S., Kang S.M. Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus. Vaccine 2014, 32:5866-5874.
22. Leemans J.C., Juffermans N.P., Florquin S., van Rooijen N., Vervoordeldonk M.J., Verbon A., van Deventer S.J., van der Poll T. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 2001, 166:4604-4611.
23. Lukens M.V., Kruijsen D., Coenjaerts F.E., Kimpen J.L., van Bleek G.M. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J. Virol. 2009, 83:7235-7243.
24. Melendi G.A., Hoffman S.J., Karron R.A., Irusta P.M., Laham F.R., Humbles A., Schofield B., Pan C.H., Rabold R., Thumar B., Thumar A., Gerard N.P., Mitzner W., Barnum S.R., Gerard C., Kleeberger S.R., Polack F.P. C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. J. Virol. 2007, 81:991-999.
25. Meyerholz D.K., Griffin M.A., Castilow E.M., Varga S.M. Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model. Toxicol. Pathol. 2009, 37:249-255.
26. Olson M.R., Varga S.M. Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev. Vaccines 2008, 7:1239-1255.
27. Panuska J.R., Merolla R., Rebert N.A., Hoffmann S.P., Tsivitse P., Cirino N.M., Silverman R.H., Rankin J.A. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J. Clin. Investig. 1995, 96:2445-2453.
28. Percopo C.M., Dyer K.D., Ochkur S.I., Luo J.L., Fischer E.R., Lee J.J., Lee N.A., Domachowske J.B., Rosenberg H.F. Activated mouse eosinophils protect against lethal respiratory virus infection. Blood 2014, 123:743-752.
29. Pribul P.K., Harker J., Wang B., Wang H., Tregoning J.S., Schwarze J., Openshaw P.J. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J. Virol. 2008, 82:4441-4448.
30. Quan F.S., Huang C., Compans R.W., Kang S.M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 2007, 81:3514-3524.
31. Quan F.S., Kim Y., Lee S., Yi H., Kang S.M., Bozja J., Moore M.L., Compans R.W. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J. Infect. Dis. 2011, 204:987-995.
32. Rudraraju R., Jones B.G., Sealy R., Surman S.L., Hurwitz J.L. Respiratory syncytial virus: current progress in vaccine development. Viruses 2013, 5:577-594.
33. Sibille Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990, 141:471-501.
34. Smit J.J., Rudd B.D., Lukacs N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 2006, 203:1153-1159.
35. Stevens W.W., Kim T.S., Pujanauski L.M., Hao X., Braciale T.J. Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J. Immunol. Methods 2007, 327:63-74.
36. Stokes K.L., Chi M.H., Sakamoto K., Newcomb D.C., Currier M.G., Huckabee M.M., Lee S., Goleniewska K., Pretto C., Williams J.V., Hotard A., Sherrill T.P., Peebles R.S., Moore M.L. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 2011, 85:5782-5793.
37. Stott E.J., Taylor G. Respiratory syncytial virus. Brief review. Arch. Virol. 1985, 84:1-52.
38. Sung S.S., Fu S.M., Rose C.E., Gaskin F., Ju S.T., Beaty S.R. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 2006, 176:2161-2172.
39. Takagi H., Fukaya T., Eizumi K., Sato Y., Sato K., Shibazaki A., Otsuka H., Hijikata A., Watanabe T., Ohara O., Kaisho T., Malissen B. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 2011, 35:958-971.
40. Thepen T., Van Rooijen N., Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 1989, 170:499-509.
41. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A., Van Rooijen N., Katz J.M., Basler C.F. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005, 79:14933-14944.
42. van Rooijen N., Bakker J., Sanders A. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol. 1997, 15:178-185.
43. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
44. Varga S.M., Wissinger E.L., Braciale T.J. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J. Immunol. 2000, 165:6487-6495.
45. Wang H., Peters N., Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 2006, 177:6263-6270.